MARKET

ACIU

ACIU

AC Immune
NASDAQ
2.040
-0.070
-3.32%
Closed 16:45 07/11 EDT
OPEN
2.090
PREV CLOSE
2.110
HIGH
2.105
LOW
2.030
VOLUME
86.22K
TURNOVER
0
52 WEEK HIGH
4.260
52 WEEK LOW
1.430
MARKET CAP
204.84M
P/E (TTM)
-3.4617
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at ACIU last week (0707-0711)?
Weekly Report · 34m ago
Weekly Report: what happened at ACIU last week (0630-0704)?
Weekly Report · 07/07 11:35
Weekly Report: what happened at ACIU last week (0623-0627)?
Weekly Report · 06/30 11:42
Weekly Report: what happened at ACIU last week (0616-0620)?
Weekly Report · 06/23 11:34
AC Immune SA Announces AGM Results and Strategic Approvals
TipRanks · 06/20 10:28
Weekly Report: what happened at ACIU last week (0609-0613)?
Weekly Report · 06/16 11:42
AC Immune SA Announces Leadership Changes in Development Team
TipRanks · 06/11 20:27
Weekly Report: what happened at ACIU last week (0602-0606)?
Weekly Report · 06/09 11:43
More
About ACIU
AC Immune SA is a Switzerland-based clinical-stage biopharmaceutical company. The Company focuses on precision medicine for neurodegenerative diseases. It designs, discovers and develops therapeutic, as well as diagnostic products for prevention, diagnosis and treatment of diseases caused by misfolding proteins. Its SupraAntigen and Morphomer technology platforms to create antibodies, small molecules and vaccines designed to address a broad range of neurodegenerative indications, such as Alzheimer's disease (AD). The Company's pipeline includes nine therapeutic product candidates with five in clinical trials, and three diagnostic candidates. Its lead product candidate is Crenezumab, a humanized and monoclonal anti-Abeta antibody for Alzheimer’s disease. It has collaborations with pharmaceutical companies, including Roche/Genentech, Eli Lilly, Biogen, Janssen Pharmaceuticals, Nestle Institute of Health Sciences, Life Molecular Imaging (formerly Piramal Imaging) and Essex Bio-Technology.

Webull offers AC Immune SA stock information, including NASDAQ: ACIU real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ACIU stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading ACIU stock methods without spending real money on the virtual paper trading platform.